Advertisement
UK markets close in 21 minutes

  • FTSE 100

    8,060.86
    +20.48 (+0.25%)
     

  • FTSE 250

    19,586.47
    -132.90 (-0.67%)
     

  • AIM

    752.84
    -1.85 (-0.25%)
     

  • GBP/EUR

    1.1654
    +0.0009 (+0.08%)
     

  • GBP/USD

    1.2484
    +0.0021 (+0.17%)
     

  • Bitcoin GBP

    50,798.07
    -1,323.55 (-2.54%)
     

  • CMC Crypto 200

    1,371.70
    -10.87 (-0.79%)
     

  • S&P 500

    5,004.84
    -66.79 (-1.32%)
     

  • DOW

    37,817.81
    -643.11 (-1.67%)
     

  • CRUDE OIL

    82.16
    -0.65 (-0.78%)
     

  • GOLD FUTURES

    2,346.80
    +8.40 (+0.36%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     

  • DAX

    17,883.50
    -205.20 (-1.13%)
     

  • CAC 40

    8,006.06
    -85.80 (-1.06%)
     
Stocks:

Trending tickers

Microsoft, Alphabet, Anglo American, IBM, Astrazeneca, Unilever and Sainsbury's

Got $5,000? These 2 Stocks Are Crushing the Market This Year

David Jagielski, The Motley Fool
·4-min read

A couple of stocks that are doing exceptionally well this year are Veru (NASDAQ: VERU) and Chevron (NYSE: CVX). Pharmaceutical company Veru has been among the hottest stocks to own this year, having more than doubled in value while the S&P 500 is firmly in negative territory, down 13%. The company and its investors are hoping that the Food and Drug Administration (FDA) grants it Emergency Use Authorization (EUA) as phase 3 trials have shown it is effective in reducing the risk of death among hospitalized patients.

Continue reading